How to pronounce “kettering” in English

"Adams Kettering," Robinson said.

at the Memorial Sloan Kettering Cancer Center in New York City.

been doing at Sloan Kettering.

And I'm lecturing at Sloan Kettering and partnering with Sloan Kettering.

So I've been at Sloan Kettering now it's 18 years.

He has an engineering degree from Kettering University and a graduate degree in science and technology from University of Amsterdam.

first visit to Memorial Sloan Kettering Cancer Center in New York City.

And so this is what we're doing at Sloan Kettering.

We've also made a decision at Sloan Kettering that we're going to make the data that we generate using this assay available to everyone at the Center

And this data's now available to everyone at Sloan Kettering.

And so we've created this initiative at Sloan Kettering.

He will be actually starting a fellowship in New York at Sloan Kettering next year in pediatric hematology oncology.

And for no particular reason other than it was an open clinical trial at Sloan Kettering at the time, this woman enrolled on the Everolimus study.

So if you look at our series of this type of cancer at Sloan Kettering over the past 10 years, essentially all patients with this disease

1997, I was a trainee at Sloan-Kettering.

had to run to New Jersey to see my mom, go to Memorial Sloan-Kettering to be with Peter during his appointment, oh, pick up my daughter from daycare and the nanny,

But for me to be able to get access to work with the Cleveland Clinic and Sloan Kettering, it had to be a gift.

And the real inspiration for this work was this clinical trial that we ran in Sloan Kettering a few years ago.

DAVID B. SOLIT: So we've created this initiative at Sloan Kettering.

What we're trying to do here is we're trying to sequence every single patient with advanced metastatic cancer at Sloan Kettering using

And so we see about 45,000 unique patients with cancer at Sloan Kettering every single year.

And so we've got about 10,000 to 12,000 patients like that at Sloan Kettering every year.

She serves on the board of MIT, PureTech Health, Memorial Sloan Kettering Cancer Center, Infosys, Narayana Health,

Carroll-- excuse me, Bill Fair-- who, at the time, was the Chair of Urology at Memorial Sloan Kettering Cancer Center.